Cigna and Fresenius will extend their partnership into 2023, hoping it will continue lowering costs and reducing unnecessary hospitalizations for those with kidney disease.
from Section Page News - Modern Healthcare https://ift.tt/3D4D1eP
Health tips in Tamil and English & more unique news updates too, " Health is wealth " so, Read data and be strong and healthy!!
Cigna and Fresenius will extend their partnership into 2023, hoping it will continue lowering costs and reducing unnecessary hospitalizations for those with kidney disease.
Valtruis, a newly launched portfolio company focused on value-based care, invested the most, with additional money from Cigna and Blue Shield of California, two Cricket Health customers.
UnitedHealthcare, Aetna and Cigna have all unveiled policies this year that force patients to switch to biosimilars or restrict the biologic drug dosage an individual can receive.